Intimate Bridge 2 Conception developing an OTC take-home insemination device
PITTSBURGH — A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday. The product will be submitted for Food and Drug Administration approval in the first half of 2011. If approved, Steve Bollinger first plans to introduce the product into doctor’s offices before launching through retail pharmacy.
Bollinger, CEO of Intimate Bridge 2 Conception, hopes to introduce Focus Touch at an $80 price point by the end of the year, following FDA approval. Bollinger already has raised $500,000 in investments from the Pittsburgh Life Sciences Greenhouse and local incubator Innovation Works, the Post-Gazette reported, and expects to close on a second round of funding worth $1.5 million in March.
The Focus Touch is designed to allow do-it-yourself intracervical insemination, a process that places semen right near the cervix to increase the chance of a pregnancy. The kit will include a specially designed condom to collect the semen in a small cap; the small cap is then removed and fitted onto a long, thin tube for insemination. “The cap can stay inside the woman’s body for three to five hours before being pulled out by a string, much like a tampon,” the paper reported.
The cap also can be stored in a refrigerated climate for up to seven days.
Intracervical insemination has a success rate of 10% to 15%, Bollinger reported.
Walgreens vet Michael Tovian, a one-time VP managed care sales and contracting, sits on IB2C’s board.
For the complete story, click here.
How was this project going? Did the company have the device already? If yes, what are the progress and benefits it contributed to the company? I have heard that they will also build a bridge but they still have to present approval to bid & certifications to be used for the products during delivery from different places.
Puralube re-enters market
NEW YORK — Fera Pharmaceuticals on Wednesday announced the reintroduction of the nonprescription dry-eye remedy Puralube ophthalmic ointment due to demand for the product.
“Puralube is a product that fits perfectly with our eye care portfolio,” stated Frank DellaFera, president of Fera. “We are so pleased to make Puralube available again, giving patients, pharmacists and physicians a cost-effective and reliable treatment option for dry-eye symptoms.”
Fera is launching Puralube in a 3.5-g tube and a carton of 20 1-g tubes. It will be available through retail, wholesale and mail-order pharmacy, the company stated.
No comments found
Alka-Seltzer kicks off Facebook contest
MORRISTOWN, N.J. — Bayer HealthCare on Wednesday launched the Said/Heard Mishaps contest on its Alka-Seltzer Facebook page. The contest gives entrants the opportunity to trade those miscommunication experiences that may have caused some gastrointestinal distress for a chance to win $5,000.
The Alka-Seltzer Facebook page features its iconic "Speedy" character, who kicked off the contest with his Facebook debut and a call to action for consumers to enter the Said/Heard Mishaps contest. Through Feb. 25, consumers can enter by visiting Facebook.com/AlkaSeltzerOriginal and sharing their funny miscommunications mishap.
The grand prize winner will receive a complimentary trip for two to New York City to star in an Alka-Seltzer online video featuring his or her entry. The online video will premiere on the Alka-Seltzer Facebook page and the winner also will receive a $5,000 cash prize.
As part of the brand’s new marketing campaign featuring the return and revitalization of Speedy, the contest replicates the recent Alka-Seltzer advertising campaign that features miscommunication spots, such as "College Acceptance" and "Promotion," while giving consumers direct engagement with Alka-Seltzer and reintroducing them to Speedy through the Facebook platform.
No comments found